Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 494 entries
View as:

802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT03637387 Org: User:
Start: 03/01/23 End: 09/29/26 Due: 09/29/27

Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01563562 Org: User:
Start: 04/30/12 End: 11/30/12 Due: 11/30/13

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00811889 Org: User:
Start: 04/30/09 End: 12/31/10 Due: 12/31/11

Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03264079 Org: User:
Start: 10/16/17 End: 11/13/17 Due: 11/13/18

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

Phase: N/A Priority: Normal
NCT ID: NCT00534261 Org: User:
Start: 11/30/99 End: 02/29/04 Due: 02/28/05

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Phase: N/A Priority: Normal
NCT ID: NCT00168766 Org: User:
Start: 01/31/03 End: 11/30/08 Due: 11/30/09

A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00288990 Org: User:
Start: 01/31/06 End: 08/31/07 Due: 08/31/08

Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT04288856 Org: User:
Start: 04/28/20 End: 05/03/22 Due: 05/03/23

Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003

Phase: N/A Priority: Normal
NCT ID: NCT02658916 Org: User:
Start: 02/22/16 End: 03/31/20 Due: 03/31/21

Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Phase: N/A Priority: Normal
NCT ID: NCT01561027 Org: User:
Start: 04/30/11 End: 08/31/12 Due: 08/31/13

Study of Natalizumab in Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00675428 Org: User:
Start: 09/30/08 End: 12/31/09 Due: 12/31/10

Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT03224793 Org: User:
Start: 10/04/17 End: 06/12/18 Due: 06/12/19

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

Phase: N/A Priority: Normal
NCT ID: NCT00168740 Org: User:
Start: 04/30/95 End: - Due: -

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen

Phase: N/A Priority: Normal
NCT ID: NCT02076841 Org: User:
Start: 07/31/13 End: 10/31/16 Due: 10/31/17

Absorption, Metabolism, and Excretion Study of BIIB074

Phase: N/A Priority: Normal
NCT ID: NCT02751905 Org: User:
Start: 04/30/16 End: 05/31/16 Due: 05/31/17

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01351675 Org: User:
Start: 06/30/11 End: 12/31/12 Due: 12/31/13

Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00964288 Org: User:
Start: 07/31/09 End: 11/30/09 Due: 11/30/10

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT04961567 Org: User:
Start: 07/16/21 End: 03/16/27 Due: 03/16/28

TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants

Phase: N/A Priority: Normal
NCT ID: NCT05236777 Org: User:
Start: 01/01/19 End: 04/30/25 Due: 04/30/26

Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00438607 Org: User:
Start: 04/30/07 End: 04/30/09 Due: 04/30/10

Long-Term Evaluation of BIIB067 (Tofersen)

Phase: N/A Priority: Normal
NCT ID: NCT03070119 Org: User:
Start: 03/08/17 End: 08/12/24 Due: 08/12/25

A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03347370 Org: User:
Start: 11/27/17 End: 07/31/19 Due: 07/31/20

Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00906399 Org: User:
Start: 06/30/09 End: 10/31/13 Due: 10/31/14

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00616434 Org: User:
Start: 05/31/08 End: 03/31/10 Due: 03/31/11

Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01689116 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13